2022 Q4 Form 20-F Financial Statement

#000117891323001545 Filed on April 27, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $45.19M $150.6M $36.30M
YoY Change 24.49% 17.22% 7.09%
Cost Of Revenue $30.20M $98.63M $23.76M
YoY Change 27.14% 17.31% -2.19%
Gross Profit $14.99M $51.96M $12.55M
YoY Change 19.47% 17.05% 30.55%
Gross Profit Margin 33.17% 34.5% 34.56%
Selling, General & Admin $2.851M $11.47M $3.090M
YoY Change -7.73% 2.02% 14.02%
% of Gross Profit 19.02% 22.07% 24.63%
Research & Development $5.076M $20.56M $5.102M
YoY Change -0.51% 2.35% -5.52%
% of Gross Profit 33.86% 39.58% 40.67%
Depreciation & Amortization $2.415M
YoY Change -0.9%
% of Gross Profit 4.65%
Operating Expenses $7.927M $32.03M $8.192M
YoY Change -3.23% 2.23% 1.01%
Operating Profit $7.062M $19.93M $4.354M
YoY Change 62.2% 52.61% 190.27%
Interest Expense $439.0K $2.464M -$556.0K
YoY Change -178.96% -1721.05% -4.14%
% of Operating Profit 6.22% 12.37% -12.77%
Other Income/Expense, Net $2.464M
YoY Change -1721.05%
Pretax Income $7.501M $22.39M $3.798M
YoY Change 97.5% 73.5% 312.83%
Income Tax $1.880M $4.084M $504.0K
% Of Pretax Income 25.06% 18.24% 13.27%
Net Earnings $5.621M $18.31M $3.294M
YoY Change 70.64% 73.66% 287.53%
Net Earnings / Revenue 12.44% 12.16% 9.07%
Basic Earnings Per Share $2.73
Diluted Earnings Per Share $0.82 $2.69 $478.3K
COMMON SHARES
Basic Shares Outstanding 6.739M shares 6.697M shares
Diluted Shares Outstanding 6.796M shares

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.75M $34.75M $37.55M
YoY Change -7.45% -7.45% -38.24%
Cash & Equivalents $30.73M $30.73M $29.29M
Short-Term Investments $4.020M $4.020M $8.266M
Other Short-Term Assets $900.0K
YoY Change 17.19%
Inventory $87.99M $87.99M $75.75M
Prepaid Expenses $936.0K $768.0K
Receivables $27.26M $27.26M $31.12M
Other Receivables $3.620M $3.620M $4.693M
Total Short-Term Assets $153.6M $153.6M $149.1M
YoY Change 3.02% 3.02% 9.48%
LONG-TERM ASSETS
Property, Plant & Equipment $12.93M $12.93M $13.34M
YoY Change -3.09% -3.09% -4.71%
Goodwill $25.56M $25.56M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $15.16M $15.16M $23.77M
YoY Change -36.22% -36.22% 55.38%
Other Assets $2.217M $2.217M $3.498M
YoY Change -36.62% -36.62% -2.83%
Total Long-Term Assets $62.58M $62.58M $70.49M
YoY Change -11.22% -11.22% 18.07%
TOTAL ASSETS
Total Short-Term Assets $153.6M $153.6M $149.1M
Total Long-Term Assets $62.58M $62.58M $70.49M
Total Assets $216.2M $216.2M $219.6M
YoY Change -1.55% -1.55% 12.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.56M $25.56M $29.92M
YoY Change -14.56% -14.56% 104.92%
Accrued Expenses $1.549M $1.549M $1.811M
YoY Change -14.47% -14.47% 0.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $27.11M $27.11M $50.31M
YoY Change -46.11% -46.11% 71.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.716M $9.716M $10.82M
YoY Change -10.2% -10.2% -5.91%
Total Long-Term Liabilities $9.716M $9.716M $10.82M
YoY Change -10.2% -10.2% -5.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.11M $27.11M $50.31M
Total Long-Term Liabilities $9.716M $9.716M $10.82M
Total Liabilities $36.90M $36.90M $61.14M
YoY Change -39.64% -39.64% 48.76%
SHAREHOLDERS EQUITY
Retained Earnings $147.6M $130.0M
YoY Change 13.51%
Common Stock $66.56M $63.39M
YoY Change 4.99%
Preferred Stock
YoY Change
Treasury Stock (at cost) $34.90M $35.00M
YoY Change -0.28%
Treasury Stock Shares 933.9K shares 960.5K shares
Shareholders Equity $179.3M $179.3M $158.5M
YoY Change
Total Liabilities & Shareholders Equity $216.2M $216.2M $219.6M
YoY Change -1.55% -1.55% 12.1%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income $5.621M $18.31M $3.294M
YoY Change 70.64% 73.66% 287.53%
Depreciation, Depletion And Amortization $2.415M
YoY Change -0.9%
Cash From Operating Activities -$4.090M
YoY Change -479.05%
INVESTING ACTIVITIES
Capital Expenditures $2.089M
YoY Change -133.92%
Acquisitions
YoY Change
Other Investing Activities $12.97M
YoY Change -43.42%
Cash From Investing Activities $8.273M
YoY Change -50.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$1.051M
YoY Change -89.25%
NET CHANGE
Cash From Operating Activities -$4.090M
Cash From Investing Activities $8.273M
Cash From Financing Activities -$1.051M
Net Change In Cash $1.449M
YoY Change -82.04%
FREE CASH FLOW
Cash From Operating Activities -$4.090M
Capital Expenditures $2.089M
Free Cash Flow -$6.179M
YoY Change -185.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4693000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3620000 usd
CY2022 dei Auditor Firm
AuditorFirmId
1309
CY2022 dei Auditor Name
AuditorName
Kesselman & Kesselman
CY2022 dei Auditor Location
AuditorLocation
Tel-Aviv, Israel
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
960505 shares
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
933933 shares
CY2020 silc Stock Shares Issued During Period Value Stock Options Exercised And Restricted Stock Units
StockSharesIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockUnits
276000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
154837000 usd
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1578000 usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5246000 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3002000 usd
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
276000 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0px;margin-bottom:0pt"> <p style="margin:0pt"> </p> <div style="margin-left:36pt"> <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"> <tr> <td style="width:36pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>C.</span></span></span></span></span></span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>Estimates and assumptions</strong></span></span></span></span></span></span></p> </td> </tr> </table> </div> <p style="margin-left:72pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>T</span></span></span></span><span>he preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include revenue recognition over time, credit loss, income taxes, impairment of inventories, marketable securities, impairment of goodwill, intangible assets and the assumptions used to estimate the fair value of share-based compensation.</span></span></span></p> </div> </div>
CY2022Q4 silc Cumulative Amount Of Earnings Of Foreign Subsidiaries Upon Which Deferred Taxes Not Provided
CumulativeAmountOfEarningsOfForeignSubsidiariesUponWhichDeferredTaxesNotProvided
16300000 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:12pt;text-indent:36pt;margin-bottom:0pt"> <div style="font-weight:bold;text-indent:0px"> <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"> <tr> <td style="width:36pt;vertical-align:top;align:right;font-weight:bold"> </td> <td style="width:36pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong><span>X.</span></strong></span></span></span></span></span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>Concentrations of risks</strong></span></span></span></span></span></span></p> </td> </tr> </table> </div> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:12pt;margin-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1)          <span style="text-decoration:underline"><span>Credit risk</span></span></span></span></span></span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:10pt;margin-left:108pt;margin-bottom:0pt;text-indent:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Financial instruments, which potentially subject the Company to significant concentrations of credit risk, consist principally of cash and cash equivalents, marketable securities, trade receivables and assets held for employees’ severance benefits. Cash and cash equivalents balances of the Company, which are subject to credit risk, consist of cash accounts held with major financial institutions. Marketable securities consist of held to maturity marketable securities issued by highly rated corporations. As of December 31, 2021 and 2022, the ratings of the securities in the Company's portfolio was at least A-. Nonetheless, these investments are subject to general credit and counterparty risks (such as that the counterparty to a financial instrument fails to meet its contractual obligations). The Company closely monitors extensions of credit and has never experienced significant credit losses.</span></span></span></span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:72pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(2)          <span style="text-decoration:underline"><span>Significant customers</span></span></span></span></span></span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:10pt;margin-bottom:0pt;margin-left:108pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Company's top four ultimate customers accounted for approximately 33% of its revenues in 2022. The Company expects that a small number of customers will continue to account for a significant portion of its revenues for the foreseeable future. See Note 13.</span></span></span></span></span></span></div> </div>
CY2022 silc Number Of Major Customers
NumberOfMajorCustomers
4 customer
CY2022 silc Revenues From Major Customers
RevenuesFromMajorCustomers
0.33 pure
CY2020 silc Operating Leases Right Of Use Assets
OperatingLeasesRightOfUseAssets
7201000 usd
CY2021 silc Operating Leases Right Of Use Assets
OperatingLeasesRightOfUseAssets
451000 usd
CY2022 silc Operating Leases Right Of Use Assets
OperatingLeasesRightOfUseAssets
1269000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
661062 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
364715 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
9129000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3457000 usd
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
5300000 usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2887000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2334000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
600000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3994000 usd
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y2M12D
CY2020 us-gaap Interest Income Other
InterestIncomeOther
2197000 usd
CY2021 us-gaap Interest Income Other
InterestIncomeOther
1548000 usd
CY2022 us-gaap Interest Income Other
InterestIncomeOther
1144000 usd
CY2020 silc Changes In Marketable Securities Net
ChangesInMarketableSecuritiesNet
244000 usd
CY2021 silc Changes In Marketable Securities Net
ChangesInMarketableSecuritiesNet
621000 usd
CY2022 silc Changes In Marketable Securities Net
ChangesInMarketableSecuritiesNet
914000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
48000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001178913-23-001545-index-headers.html Edgar Link pending
0001178913-23-001545-index.html Edgar Link pending
0001178913-23-001545.txt Edgar Link pending
0001178913-23-001545-xbrl.zip Edgar Link pending
exhibit_12-1.htm Edgar Link pending
exhibit_12-2.htm Edgar Link pending
exhibit_13-1.htm Edgar Link pending
exhibit_13-2.htm Edgar Link pending
exhibit_15-1.htm Edgar Link pending
exhibit_15-2.htm Edgar Link pending
exhibit_4-3.htm Edgar Link pending
exhibit_4-5.htm Edgar Link pending
exhibit_4-8.htm Edgar Link pending
exhibit_4-9.htm Edgar Link pending
exhibit_8-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img45.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sig1.jpg Edgar Link pending
sig2.jpg Edgar Link pending
sig3.jpg Edgar Link pending
silc-20221231.xsd Edgar Link pending
zk2329567.htm Edgar Link pending
silc-20221231_cal.xml Edgar Link unprocessable
silc-20221231_pre.xml Edgar Link unprocessable
silc-20221231_def.xml Edgar Link unprocessable
silc-20221231_lab.xml Edgar Link unprocessable
zk2329567_htm.xml Edgar Link completed